THE FIRST AND ONLY COMBINATION HA + STEROID
CINGAL® is a novel combination HA plus steroid single-injection treatment for the pain associated with osteoarthritis. CINGAL® combines the high molecular weight cross-linked hyaluronic acid (HA) formulation of MONOVISC® with a corticosteroid for additional short-term pain relief.
CINGAL® is indicated as a viscoelastic supplement or a replacement for synovial fluid in human joints. CINGAL® is well suited for rapid and long term relief of the symptoms of human joint dysfunctions such as osteoarthritis. The actions of CINGAL® are long term relief of symptoms by lubrication and mechanical support supplemented by short-term pain relief provided by triamcinolone hexacetonide.
Direction for use
The pre-filled syringe is intended for single use only. The contents of the syringe should be used immediately after opening. Discard any unused CINGAL®. Do not resterilize.
• Store at 2 to 25 ̊C. Protect from freezing. Refrigerated CINGAL® should be allowed to reach room temperature (approx. 20-45 min.) prior to use.
• Only medical professionals trained in accepted injection techniques for delivering agents into the knee joint should inject CINGAL® for the indicated use.
The product contains 22 mg/mL high molecular weight cross- linked hyaluronic acid produced from bacterial fermentation, 4.5 mg/mL triamcinolone hexacetonide.
CINGAL® is supplied as a 4 mL unit dose in a terminally-sterilized 5 mL glass syringe.